1 insiders reported 1 Form 4 transactions for enGene Therapeutics Inc. (ENGN) over the past 18 months (most recent 2026-09-24). Recent activity: Grossman William (Interim Chief Medical Officer) Buy 5,102 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Grossman William | Interim Chief Medical Officer | Buy | 5,102 | $10,051 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24